Falcon Wealth Planning’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$317K Buy
5,088
+1,181
+30% +$74.6K 0.02% 192
2026
Q2
$225K Sell
3,907
-659
-14% -$37.8K 0.01% 232
2026
Q1
$277K Sell
4,566
-2,882
-39% -$168K 0.02% 189
2025
Q4
$402K Buy
7,448
+1,632
+28% +$78.5K 0.03% 138
2025
Q3
$262K Buy
+5,816
New +$272K 0.02% 161

Other funds holding BMY

Falcon Wealth Planning's BMY Position: Q3 2026 in Review

Falcon Wealth Planning increased its Bristol-Myers Squibb (BMY) stake by 30% in Q3 2026, buying an estimated $74.6K and bringing the position to 5,088 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #192.

Falcon Wealth Planning first reported a position in BMY in Q3 2025 and has held it in 5 quarters since. The position peaked at $402K in Q4 2025. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Falcon Wealth Planning held 5,088 shares of Bristol-Myers Squibb worth $317K as of Q3 2026.
  • Falcon Wealth Planning bought 1,181 Bristol-Myers Squibb shares in Q3 2026, an estimated $74.6K.
  • Bristol-Myers Squibb made up 0.02% of Falcon Wealth Planning's portfolio in Q3 2026, its #192 holding.
  • Falcon Wealth Planning first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 5 quarters since.
  • Falcon Wealth Planning's Bristol-Myers Squibb position peaked at $402K in Q4 2025.
  • 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Falcon Wealth Planning's 13F filing for Q3 2026, filed 6 Nov 2026.